Risk factors predicting progression of diabetic retinopathy over six years in 1579 NIDDM patients

Risk factors predicting progression of diabetic retinopathy over six years in 1579 NIDDM patients

Bibliographische Detailangaben
Hauptverfasser:	Stratton, I, Kohner, E, Matthews, DR, Holman, R, Aldington, S, Turner, R
Format:	Journal article
Veröffentlicht:	1996

Ähnliche Einträge

PROGRESSION OF DIABETIC-RETINOPATHY OVER 6 YEARS IN PATIENTS STUDIED IN THE UK PROSPECTIVE DIABETES STUDY
von: Aldington, S, et al.
Veröffentlicht: (1994)

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.
von: Stratton, I, et al.
Veröffentlicht: (2001)

Nine-year status of diabetic retinopathy and photocoagulation in the UK prospective diabetes study.
von: Aldington, S, et al.
Veröffentlicht: (1996)

PROGRESSION OF DIABETIC-RETINOPATHY IN TYPE-2 DIABETIC-PATIENTS IN THE UK PROSPECTIVE DIABETES STUDY
von: Stratton, I, et al.
Veröffentlicht: (1993)

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).
von: Kohner, E, et al.
Veröffentlicht: (2001)

RETINOPATHY IN THE UKPDS TRIAL MICRO-ANEURYSM COUNTS AND THE RISKS OF PROGRESSION OVER 3-YEARS AND 6-YEARS
von: Matthews, D, et al.
Veröffentlicht: (1995)

Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
von: Matthews, DR, et al.
Veröffentlicht: (2004)

Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group.
von: Kohner, E, et al.
Veröffentlicht: (1999)

United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors.
von: Kohner, E, et al.
Veröffentlicht: (1998)

PREVALENCE OF RETINOPATHY AT DIAGNOSIS OF TYPE-II DIABETES IN THE UK PROSPECTIVE DIABETES STUDY
von: Kohner, E, et al.
Veröffentlicht: (1993)

PREVALENCE OF DIABETIC-RETINOPATHY AT DIAGNOSIS OF NON-INSULIN-DEPENDENT DIABETES IN THE UNITED-KINGDOM PROSPECTIVE DIABETES STUDY
von: Kohner, E, et al.
Veröffentlicht: (1993)

PREVALENCE OF DIABETIC-RETINOPATHY AT DIAGNOSIS OF NON-INSULIN-DEPENDENT DIABETES IN 2964 WHITE CAUCASIAN SUBJECTS AND ASSOCIATION WITH HYPERTENSION, HYPERGLYCEMIA AND IMPAIRED BETA-CELL FUNCTION
von: Stratton, I, et al.
Veröffentlicht: (1995)

Effects of ethnicity on metabolic control during the first six years of NIDDM
von: Davis, T, et al.
Veröffentlicht: (1997)

Evaluating risk of progression to photocoagulation by retinal photography or direct ophthalmoscopy.
von: Stratton, I, et al.
Veröffentlicht: (1997)

U.K. Prospective Diabetes Study 22. Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM.
von: Davis, T, et al.
Veröffentlicht: (1997)

Treatment of NIDDM - Progressive requirement for polypharmacy to attain glycaemic goals
von: Cull, C, et al.
Veröffentlicht: (1997)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
von: Matthews, DR, et al.
Veröffentlicht: (1998)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
von: Matthews, DR, et al.
Veröffentlicht: (1998)

Glycaemic improvement over one year in a double-blind trial of acarbose in 1,946 NIDDM patients
von: Holman, R, et al.
Veröffentlicht: (1996)

UK prospective diabetes study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM.
von: Keavney, B, et al.
Veröffentlicht: (1995)

Risk factors for presence of hard exudates at diagnosis of Type 2 diabetes and after 6 years.
von: Stratton, J, et al.
Veröffentlicht: (2003)

Insulin use in NIDDM. Rationale based on pathophysiology of disease.
von: Turner, R, et al.
Veröffentlicht: (1990)

No glycemic benefit from guar administration in NIDDM.
von: Holman, R, et al.
Veröffentlicht: (1987)

CIGMA as a tool in the study of NIDDM.
von: Turner, R, et al.
Veröffentlicht: (1988)

UK PROSPECTIVE DIABETES STUDY 16 - OVERVIEW OF 6 YEARS THERAPY OF TYPE-II DIABETES - A PROGRESSIVE DISEASE
von: Turner, R, et al.
Veröffentlicht: (1995)

The influence of background diabetic retinopathy in the second eye on rates of progression of diabetic retinopathy between 2005 and 2010.
von: Scanlon, P, et al.
Veröffentlicht: (2013)

Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy.
von: Scanlon, P, et al.
Veröffentlicht: (2014)

Coronary heart disease and risk factors in NIDDM--experience from the United Kingdom Prospective Diabetes Study.
von: Turner, R, et al.
Veröffentlicht: (1997)

Epidemiological issues in diabetic retinopathy.
von: Scanlon, P, et al.
Veröffentlicht: (2013)

Pathogenesis of NIDDM--a disease of deficient insulin secretion.
von: Turner, R, et al.
Veröffentlicht: (1988)

Sulphonylurea therapy over six years does not delay progression to diabetes
von: Herlihy, O, et al.
Veröffentlicht: (2000)

U.K. Prospective Diabetes Study. XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM.
von: Dudley, C, et al.
Veröffentlicht: (1995)

A Practical Manual of Diabetic Retinopathy Management
von: Scanlon, P, et al.
Veröffentlicht: (2009)

Personalised risk estimation for progression to sight-threatening diabetic retinopathy: how much does clinical information add to screening data?
von: Stratton, I, et al.
Veröffentlicht: (2014)

Post-prandial amylin concentrations are increased by sulphonylurea, but unchanged by basal insulin, in NIDDM
von: Rachman, J, et al.
Veröffentlicht: (1996)

Segregation analysis of NIDDM in Caucasian families.
von: Cook, J, et al.
Veröffentlicht: (1994)

STUDY DESIGN OF THE UK PROSPECTIVE DIABETES STUDY AND PROGRESS OF EYE DATA
von: Stratton, I, et al.
Veröffentlicht: (1993)

Reinforced healthy living advice over six years does not delay progression to diabetes
von: Dyson, P, et al.
Veröffentlicht: (2000)

Thyroid dysfunction and its relation with diabetes mellitus (NIDDM)
von: H.R.Bazrafshan (M.D), et al.
Veröffentlicht: (2000-03-01)

Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
von: Rachman, J, et al.
Veröffentlicht: (1998)